Kaduna Reps member, Aliyu, dies at 53

The newly sworn-in mmber of the House of Representatives, representing Lere Federal Constituency of Kaduna State, Hon Suleiman Aliyu is dead.

The 53-year-old Hon Aliyu’s death was announced barely a week after the demise of his contemporary, member representing Jos North/Bassa Federal Constituency of Plateau State, Hon. Haruna Maitala aged 70, who died in a ghastly motor accident alongside his son and Legislative Aide on their way to Jos from Abuja.

According to the report, made available to newsmen, Hon Aliyu died Tuesday afternoon at the Barau Dikko Teaching Hospital, Kaduna State after a brief illness.

The lawmaker was recently declared winner of February 23, 2019, House of Representatives election which also reinstated him as the candidate of All Progressive Congress (APC) via the Court of Appeal judgement.

Other lawmakers who died since the inauguration of the 9th Assembly are; Mohammed Adamu (APC-Jigawa); Ja’afaru Iliyasu (APC-Niger); Ossy Prestige (APGA-Abia) and Yuguda Hassan Kila (APC-Jigawa), respectively.


COVID-19: Nigeria Recorded 624 New Infections Last Week, Lowest In Over Five Months

Last week, Nigeria recorded 624 new COVID-19 infections which is the lowest the country recorded in five months, Tribune Online analysis shows.

The 624 new cases reported between March 28 and April 3 is a reduction from the 849 recorded the previous week…

Inside Ibadan Bound Train From Lagos

The train started the 156.65 kilometres journey to Lagos at exactly 08:00hrs. The pace of its acceleration was minimal.

At about 25 minutes, the train slowed down at the uncompleted Omi-Adio terminal, a village on the Abeokuta/Ibadan expressway; it’s a stone throw from Apata in Ibadan. Conveyance of passengers from there and other terminals has not kickstarted as the terminals are still under construction and workers were found there…Kaduna Reps member, Aliyu, dies at 53

Kaduna Reps member, Aliyu, dies at 53

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More